TrialProceedings of the National Academy of Sciences of the United States of America1999

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma.

G D Demetri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.